ArticleDiscover oncology2026

Integrative immunogenomic profiling identifies CALU as a brown adipocyte-linked modulator of progression and treatment response in pancreatic cancer.

Fang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.